MedTrace Logo

Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice

NCT04049188 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2020-01-23

No results posted yet for this study

Summary

Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on cancer patients with bone metastases enrolled in hospice care.

Conditions

  • Cancer Metastatic

Interventions

RADIATION

Single-Fraction Palliative Radiation Therapy

All subjects will be undergo single-fraction palliative radiation therapy who have cancer and associated bone metastases and symptomatic bone pain.

Sponsors & Collaborators

  • OHSU Knight Cancer Institute

    collaborator OTHER

  • Oregon Health and Science University

    collaborator OTHER

  • Care Partners

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-01-01
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04049188 on ClinicalTrials.gov